In This Section
- News & Articles
- Media Inquiries
Avandia: Senate Report Heightens Concerns Over Diabetes Drug Heart Attack Risks
U.S. Senate Releases New Report Linking Avandia to Heart RisksFebruary 22, 2010
Senators Max Baucus and Charles E. Grassley released a report on Feburary 20, 2010 asking the Food and Drug Administration why it allowed a clinical trial of Avandia to continue after it estimated the drug caused over 80,000 heart attacks between 1999 and 2007.
As reported in the Washington Post, New York Times and various other national publications, the Pharmaceutical giant GlaxoSmithKline knew of possible heart attack risks tied to its controversial diabetes drug Avandia years before evidence of a link became public, according to a U.S. Senate report.
The Wall Street Journal is now reporting that the FDA is recommending Avandia be pulled from the market.
You can read the complete 2007 Safety Summary, including a link to the FDA News Release and Prescribing Information regarding is issue at: http://www.fda.gov/medwatch/safety/2007/safety07.htm#Avandia
The Simmons firm continues to investigate injury claims as a result of taking Avandia. Learn more about our on-going Avandia legal investigation.
Subscribe Via RSS